%PDF-1.7
%
1 0 obj
<>
endobj
198 0 obj
<>/Font<>>>/Fields 203 0 R>>
endobj
199 0 obj
<>stream
application/pdf
Clauber
(S36 V - M\351dico Urologista.cdr)
2012-04-29T17:23:07
PScript5.dll Version 5.2.2
2013-03-09T16:25:44-03:00
2013-03-09T16:25:44-03:00
Gnostice PDFtoolkit V2.02
uuid:b04d617e-82a8-48a5-b80e-daec21aad230
uuid:8c978bef-bee1-4794-969b-3ff069d99659
endstream
endobj
3 0 obj
<>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>>
endobj
118 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
133 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
138 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
143 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
148 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
153 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
158 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
163 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
168 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
173 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
178 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
183 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
188 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
244 0 obj
<>stream
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
/GS0 gs
q 1 0 0 1 2448.3601 437.18 cm
0 0 m
59.78 0 l
87.18 0 109.6 -23.797 109.6 -52.887 c
109.6 -65.223 l
109.6 -94.313 87.18 -118.11 59.78 -118.11 c
0 -118.11 l
-27.4 -118.11 -49.82 -94.313 -49.82 -65.223 c
-49.82 -52.887 l
-49.82 -23.797 -27.4 0 0 0 c
h
S
Q
Q
BT
0 0 0 1 k
/GS0 gs
/T1_0 11 Tf
1 0 0 1 292.9969 41.9695 Tm
(14)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 2479.1599 6638.48 cm
0 0 m
-0.77 -6162.125 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 2597.0701 378.672 cm
0 0 m
2125.72 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 234.453 378.66 cm
0 0 m
2125.717 0 l
S
Q
Q
BT
/T1_0 9 Tf
1 0 0 1 350.1119 36.9572 Tm
(FUNCAB - Funda\347\343o Professor Carlos Augusto Bittencourt)Tj
/T1_1 11 Tf
-321.962 727.922 Td
[(Entre)-512(as)-512(alternativas)-513(abaixo,)-513(assinale)-513(aquela)-513(que)]TJ
0 -12.288 TD
[(representa)-392(o)-391(alfa1-bloqueador)-393(mais)-392(potente)-392(para)-392(o)]TJ
T*
[(tratamento)-167(da)-167(hiperplasia)-168(prost\341tica)-167(benigna.)]TJ
0 -24.577 TD
[(A\))-478(Prazosina.)]TJ
0 -12.288 TD
[(B\))-478(Indoramina.)]TJ
T*
[(C\))-423(Alfuzosina.)]TJ
T*
[(D\))-423(Fenoxibenzamina.)]TJ
T*
[(E\))-478(T)111(ansulosina.)]TJ
/T1_0 11 Tf
5.903 118.755 Td
(Quest\343o 48)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 780.473 6579.4302 cm
0 0 m
1580.417 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 288.719 6638.48 cm
0 0 m
442.199 0 l
469.457 0 491.754 -22.83 491.754 -50.74 c
491.754 -67.36 l
491.754 -95.27 469.457 -118.1 442.199 -118.1 c
0 -118.1 l
-27.254 -118.1 -49.551 -95.27 -49.551 -67.36 c
-49.551 -50.74 l
-49.551 -22.83 -27.254 0 0 0 c
h
S
Q
Q
BT
/T1_1 11 Tf
1 0 0 1 28.1503 610.6008 Tm
[(Qual)-293(o)-293(tipo)-293(mais)-293(comum)-293(de)-293(tumor)-293(renal)-293(prim\341rio)-293(em)]TJ
T*
[(pacientes)-168(pedi\341tricos?)]TJ
0 -24.577 TD
[(A\))-478(Rabdomiossarcoma.)]TJ
0 -12.288 TD
[(B\))-478(Sarcoma)-167(de)-167(c\351lulas)-168(claras.)]TJ
T*
[(C\))-423(Nefroma)-167(mesobl\341stico.)]TJ
T*
[(D\))-423(Nefroblastoma.)]TJ
T*
[(E\))-478(Carcinoma)-168(de)-167(c\351lulas)-168(renais.)]TJ
0.001 -59.001 Td
[(Paciente)-598(de)-598(4)-598(anos)-598(apresenta)-598(infec\347\343o)-598(do)-598(trato)]TJ
T*
[(urin\341rio)-208(pela)-207(primeira)-207(vez.)-207(Est\341)-207(indicada)-208(investiga\347\343o)]TJ
T*
[(para)-167(refluxo)-167(vesicoureteral)-168(nesse)-167(caso:)]TJ
0 -24.577 TD
[(A\))-478(se)-167(o)-167(paciente)-168(for)-167(do)-167(sexo)-167(feminino.)]TJ
0 -12.288 TD
[(B\))-478(sempre,)-496(independentemente)-497(de)-496(qualquer)-497(outra)]TJ
16.254 -12.288 Td
(vari\341vel.)Tj
-16.254 -12.288 Td
[(C\))-423(se)-167(o)-167(paciente)-168(for)-167(do)-167(sexo)-167(masculino.)]TJ
T*
[(D\))-423(se)-167(houver)-167(febre)-167(associada.)]TJ
T*
[(E\))-478(apenas)-168(ap\363s)-167(o)-167(segundo)-168(epis\363dio)-168(de)-167(infec\347\343o.)]TJ
/T1_0 11 Tf
5.902 276.062 Td
(Quest\343o 49)Tj
0 -145.019 TD
(Quest\343o 50)Tj
ET
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 780.477 5293.7798 cm
0 0 m
1580.413 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 780.48 4085.29 cm
0 0 m
1580.42 0 l
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 288.723 5352.8398 cm
0 0 m
442.203 0 l
469.457 0 491.754 -22.84 491.754 -50.75 c
491.754 -67.37 l
491.754 -95.28 469.457 -118.11 442.203 -118.11 c
0 -118.11 l
-27.254 -118.11 -49.551 -95.28 -49.551 -67.37 c
-49.551 -50.75 l
-49.551 -22.84 -27.254 0 0 0 c
h
S
Q
Q
q
0.12 0 0 0.12 0 0 cm
0 0 0 1 K
4.167 w 22.926 M
q 1 0 0 1 288.73 4144.3398 cm
0 0 m
442.2 0 l
469.454 0 491.75 -22.83 491.75 -50.74 c
491.75 -67.36 l
491.75 -95.27 469.454 -118.11 442.2 -118.11 c
0 -118.11 l
-27.257 -118.11 -49.554 -95.27 -49.554 -67.36 c
-49.554 -50.74 l
-49.554 -22.83 -27.257 0 0 0 c
h
S
Q
Q
BT
ET
q
1 0 0 1 228.125 8.7720337 cm
0 g
/GS1 gs
/Fm0 Do
Q
endstream
endobj
246 0 obj
<>/Subtype/Form/Type/XObject>>stream
1 g
1 0 0 1 0 0 cm
229.625 10.272 m
365.5327 10.272 l
365.5327 22.368 l
229.625 22.368 l
229.625 10.272 l
f
endstream
endobj
104 0 obj
<>
endobj
122 0 obj
<>
endobj
126 0 obj
<>
endobj
123 0 obj
<>
endobj
125 0 obj
<>stream
xzwtTם=1.(36q7l `0*H E{|Ahz}FXbl\pI={'svgw8Git~O,lll֬Y_5MDw˿c.̻i_v'n9|+F~vo5ow馕J~]U-
$jܺxe k:){zNM9vÏ<O>%ON/|~'x/NS˿Êo8"{ۂƖcObc+K
)l+{[=ck%C6eil[-v`뱟c`%l(ۈ==mVbʰ*YF'vv+vv=v;SM;0Nc=K`"L=b4{
;at,]X/v'6v{{bMX
/6Mٌg5nV`0;?dλsw5_?7̹a
7\Q('e?-W|#7o9woOr>{[~v˃^Sjۜ'o_;P>PTT,
v@W;w
/xbvs+_wϾ/{C}W7>|/{~E\<3p7Epo ~1wէᩫA`,%w8o_C~R[zh;/}^M Z.q]
SԡχZ ޤ-_= nJ!C=ufX[/уn0^LXoҼEcRj(2c#پP_h>`LEvK(hMOD6TAJs4^r%qvjrDBѰ;ktK|.ED}ҽ@2iN'nbn5x^f#2NtwKL]}IWVSybDˀ-|ߒi0bi9M\6c)*PRk7q625OSJ*T-qLlS}[%P5T)t;]>8DZBzίrI-ҮR s5z#`q=V;9 j2w
}sQڂEppK^>ЉFyʎ- ^DÏp'L\<2>w4pބ]^6e|^e)Vգr\ꃼ/諆jhTX<^yrB)̌Aam7gHc!DAGJ 4/˓$+>yx=
aA^cvCTB)5d"Ta ~Xmx7=Jw4|6}KBp,0oN|N(L+/e/4RZKYQ+%lVd*2
c("uK:::>br1_X<lju
a@ؤRW+al+U fW2
OOo7s${՚w^$Bu'-y~}^ؾZ
ʠX!1q^x ]SULtu.;~d= oyAAcX
^ .ǟ~Wk:^z[PTKq:eкt{S\zۃ!I[^
1GŇmDS|*|qOz '
U\,ҧ`xfi3P&ߔg_3##dqr{="b^q
cU (ka$W=ʟLiNRaYdxXq$bcE.|D6G5]啔_zl<6 p[>hVD}@Y̶
6rmF$RIY1M,D0D0~@şqL kgC$[q@ 7j:("{ȚrJtB 6AI`?lP>gpHл^!f.]AᐙS#fY5ynT%dkgpg>FU 趈'r>AbOEKCy@uz}PA3ڇ KH!VzwKZQEYYe;kj^>F*G7)q"xؕ%)W![ԥ` l%y\!9 _4A)l)sה`o s} "49g9MvI@NӫZdN+A:~AP!˽:zX6 d_XSpBUxdݤ4*CQ(#1CepvxδUŢ+BAIVm܉2\O'C(og]$y @ޓ$3LDQb#IV(MmUowg$S;ӐL\xȑ ymGImK7=m5PT**(D=~3Uը35_#(MʆJҼB
'#)ce'DZ.nfY#Wfr'#sGC ⟢K &%3?EtrzD1 mAog@Fҩr
*)r*ڐ6dBKt^m"]ѮX{%%O"*-,e:Z[B{n\߬*F(@a2t&OmO4;D
>vR3
BP$cks-jdSR